Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

RPHM Reneo Pharmaceuticals Inc

18,20

0,00 (0,00%)

Nach Börsenschluss

Zuletzt aktualisiert: 01:00:00

Verzögert um 15 Minuten

Form S-1 - General form for registration of securities under the Securities Act of 1933

Article too big to display. Click here to view on the SEC website

Reneo Pharmaceuticals (NASDAQ:RPHM)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more Reneo Pharmaceuticals Charts.

Reneo Pharmaceuticals (NASDAQ:RPHM)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more Reneo Pharmaceuticals Charts.

News Reneo Pharmaceuticals Inc

Form S-8 - Securities to be offered to employees in employee benefit plans
Montag 10 März 2025 (1 Tag vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Montag 10 März 2025 (1 Tag vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 10 März 2025 (1 Tag vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Montag 10 März 2025 (1 Tag vor) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 14 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 30 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 30 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 30 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 10 Dezember 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 10 Dezember 2024 (3 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Montag 9 Dezember 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Reneo Pharmaceuticals Inc News-Artikel

SG ETC Daily Long2X Natu...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen